Recently Featured
Eye drop bottle with a dropper

Small-Molecule Eye Drop Targets Diabetic Macular Edema

November 9, 2026
A small-molecule eye drop in development at Industrial Technology Research Institute for diabetic macular edema (DME) is designed to address several disease mechanisms while offering a non-invasive alternative to treatments administered by intravitreal injection. The investigational therapy simultaneously targets Rho-associated coiled-coil kinase (ROCK) and protein kinase C (PKC) signaling pathways through a novel mechanism of…
Laboratory scene with cancer research equipment

GT Biopharma Explores GTB-5550 and KRAS Inhibitor Combination

November 9, 2026
GT Biopharma is exploring the potential of combining its investigational natural killer (NK) cell engager GTB-5550 with KRAS inhibitors following encouraging preclinical findings in pancreatic cancer models. The clinical-stage immuno-oncology company presented the new data at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, held November 4-8 in Phoenix, AZ. The research evaluated…
Business meeting in a modern office setting.

SK Biopharmaceuticals Launches U.S. Platform for Korean Life Sciences

November 9, 2026
SK Biopharmaceuticals will expand support for Korean pharmaceutical and biotechnology companies seeking to establish a presence in the U.S. The company has opened a shared business and advisory platform called SK Life Science LinX, designed to help companies navigate regulatory, clinical, and commercial challenges. A total of 31 companies have been selected to participate in…
Scientist working in a pharmaceutical lab

Nurix Stock Drops 38% as Sanofi Halts SAR448272 Development

November 9, 2026
Nurix Therapeutics suffered its worst one-day loss as a public company when Sanofi terminated development of the Phase I immunology candidate SAR448272 (NX-3911). This program was a key part of their nearly seven-year collaboration worth up to $2.5 billion to develop protein degradation drugs. Despite the termination, the collaboration continues. The trial for SAR448272 had…

Ongoing Cases